SAN DIEGO—A patient- and caregiver-targeted app reduced avoidable hospital readmissions in cirrhosis patients compared with standard of care, according to results from a new randomized controlled trial presented at The Liver Meeting 2024. The three-center study follows and extends findings of a proof-of-concept study of the app that was conducted at a single center.
“Patients with cirrhosis are really sick, and they get readmitted frequently, but what frustrates us the most is a